# FDA Hosts Advisory Meeting on Sequencing Technologies

The Food and Drug Administration (FDA) will hold a virtual public advisory committee meeting on November 19, 2026, focused on pathogen-agnostic sequencing technologies to enhance emergency preparedness and outbreak response. While this meeting does not involve direct procurement or vendor participation, it provides a critical platform for government contractors and industry stakeholders to contribute scientific and clinical expertise that may influence future regulatory guidance and technology adoption.

- **Why this matters:** Procurement professionals should note the FDA's engagement with emerging sequencing technologies that could shape future acquisition requirements for public health emergency tools.
- Industry stakeholders can leverage insights from this meeting to align product development and service offerings with anticipated FDA priorities in pathogen detection and response.
- Organizations interested in government health technology contracts may benefit from participating in or monitoring outcomes of this advisory process to anticipate evolving standards and procurement opportunities.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** September 16, 2026

### Government Entities
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)

### Sources
- [FDA announces public advisory committee meeting on pathogen-agnostic sequencing for emergency preparedness.](https://app.govly.com/opportunities/17105377) - Federal Register